I add names to my watchlist every week. I add names to my portfolio only after a portfolio stress test — a structured pass that asks what breaks if liquidity stays tight for another twelve months.

Most investors skip this. They fall in love with a comp from 2023, buy the next similar name, and discover six months later that renewals and opportunity cost dwarf the upside. I've done it too. This framework is the fix.

Run it before your next acquisition — especially if you're eyeing media-category .com names like AudioNames.com in the mid five figures.

What is a domain portfolio stress test?

It's a scenario review, not a spreadsheet fetish. You assume slower sales, flat prices, and higher capital costs — then check whether your holdings still make sense.

Think of it like a bank stress test: what happens under adverse conditions? If the answer is "I'd panic-sell at a loss," you already have your answer about buying more.

I run mine quarterly and always before any purchase above $5,000. Takes an hour if you're honest. Saves thousands if it stops one bad buy.

Buying without stress-testing is optimism. Surviving a slow market is engineering.

Step one: map renewal bleed and capital lock-up

List every name, annual renewal, acquisition cost, current ask, and days on market. Sort by longest hold first.

Renewal bleed is the silent killer. Forty names at $12 average is $480 yearly — manageable. Forty names at $35 average with three $10,000 acquisition costs unsold for 400 days is a different picture.

Capital lock-up matters more in 2026. With tighter hold rates, every dollar parked in a stale name is a dollar not available for a distressed deal or a true gem on expired drops.

Flag any name where renewal plus registrar fees exceed 2% of your realistic sale price. Those names need a plan or a cut.

Step two: comp reality, not list price fantasy

Pull closed sales on NameBio for each tier you hold. Compare your asks to the median — not the headline.

DNJournal weekly tables are useful for mood, but your portfolio needs name-level honesty. If your $14,000 ask sits 80% above the last three comps, you're carrying fiction.

Adjust for extension and category. A media .com and a fintech .app don't share the same buyer pool. Stress-test them separately.

Liquidity tiers I use

  • Tier A: Inbound inquiries in the last 90 days, comps support ask within 25%.
  • Tier B: No recent inbound, but clear end-user fit and sane pricing.
  • Tier C: No inbound, pricing stale, category soft — cut or reprice now.

If Tier C exceeds 20% of your portfolio count or capital, stop buying until you fix it. New acquisitions on top of rot just compound the problem.

Step three: legal and dispute exposure

Stress isn't only financial. A UDRP complaint on a borderline name costs time and often $4,000+ on an expedited ICANN UDRP track.

Mark any name with trademark adjacency, typosquat risk, or prior cease-and-desist. Ask whether the upside justifies dispute exposure. Sometimes the right stress-test outcome is sell at breakeven and exit.

Coined descriptive names — AudioNames for audio identity products — typically sit cleaner than single-word grabs near active brands. Factor that into acquisition filters.

Step four: exit paths under pressure

For each holding, write two exit paths: orderly sale and forced exit. Orderly means broker, marketplace, and installment option if it helps. Forced means 30% price cut, auction, or let expire.

If you can't stomach the forced exit price, you shouldn't own the name at current ask. Reprice now while you still have patience.

Our acquisition FAQ covers orderly exits for buyers; sellers should mirror the same discipline.

Should you buy more after the stress test?

Only if Tier A and B dominate and you have dry powder after renewals. I keep a simple rule: max 70% of deployable capital in active inventory, 30% reserve for opportunistic buys when someone else fails their stress test.

When a stressed seller drops a $19,000 name to $12,500 in Q4, reserve capital wins. When you're fully deployed on stale asks, you're the stressed seller.

Use domain tools and our inventory to compare new targets against your cleaned portfolio — not against your fantasy comps.

Verisign macro data won't save a messy book. Micro discipline will.

Scenario modeling: three liquidity cases

I model base, stress, and severe cases. Base assumes median hold rates from the last two quarters. Stress adds 40% to average days-on-market. Severe assumes one flagship name doesn't sell for 24 months.

If severe case breaches your cash reserve policy, don't buy until you cut or reprice. Simple spreadsheet — no Monte Carlo required.

Include broker commissions and marketplace fees in exit math. A $16,000 sale net of 15% fees and two years of renewals tells a different story than gross headline price.

Concentration limits by category

I cap any single category — AI tools, media, fintech — at 35% of portfolio capital. Category hype cycles punish concentration when sentiment flips.

Audio and media names like AudioNames can be excellent holds, but three similar stories without distinct buyer pools create correlated risk. Diversify endings and use cases.

Using drop hunting without wrecking discipline

Expired drops can be great entries, but chasing drops while Tier C inventory rots is distraction. Fix the book first, then hunt.

When you catch a drop, run the same stress test: if it doesn't sell in twelve months at a defined price, what's the exit? No answer means no buy.

How often should you rerun the test?

Quarterly for active portfolios, monthly if you're above fifty names or heavily leveraged on renewals. Markets shift — your 2025 assumptions are already stale in mid-2026.

Document each run. When you look back, you'll see which names you should have cut two quarters earlier. That hindsight trains better entries.

Renewal cliff calendar

Map renewal dates quarterly. Clusters of December renewals create year-end cash pressure that forces bad sales. Spread acquisitions or sell before the cliff.

If three high-cost renewals hit the same month, you're negotiating with yourself under stress. Calendar visibility is free alpha.

After you cut Tier C names, rerun the stress test before browsing new inventory. A clean book makes the next buy obvious — or obviously unnecessary.

Working capital and opportunity cost

Opportunity cost is the hardest line item. If $25,000 sits in unsold inventory, what's the return if it were in treasuries, index funds, or the next distressed buy?

I don't obsess over basis points, but I do ask whether a name earned its seat versus alternatives. Stress tests should feel slightly uncomfortable — comfort means you're sandbagging assumptions.

Partner and spouse test

Explain each holding in one sentence to someone outside domains. If you stumble, you may not understand the thesis — cut or clarify before buying more.

AudioNames passes the sentence test: audio identity and naming products for creators. If your sentence needs "well, eventually maybe," it's Tier C.

Stress-testing before estate or exit planning

If you might sell the portfolio itself, buyers will run their own stress test on your book. Clean Tier C cuts before a sale raise multiples more than polishing landing pages.

Buyers discount messy books with stale asks and dispute exposure. Present a portfolio you'd want to buy.

Collaboration with brokers

Share stress-test results with brokers you trust. They'll prioritize names with realistic pricing and faster closes — better for everyone than vanity asks.

Documenting decisions for your future self

Write one paragraph per name explaining why you own it and what would make you sell. Re-read quarterly. If the paragraph no longer matches reality, act.

Stress tests fail when they're performative. The output should be cut lists, reprice orders, or a justified buy — not a filed PDF nobody opens.

I keep mine in a shared doc with renewal dates bolded. Low tech, high accountability.

Before your next acquisition, ask a peer to review your stress-test output. Fresh eyes catch vanity pricing faster than spreadsheets.

The goal isn't a perfect model — it's a honest answer to whether you should buy today or clean house first.

Stress tests work only when they change behavior — cut, reprice, or buy with open eyes.

Your portfolio should get lighter or sharper each quarter, not just larger.

Run the numbers before you fall in love with the next NameBio comp — your book will thank you.

Annual review ritual

I block one Sunday per quarter for portfolio review — no acquisitions allowed that week. The rule sounds strict, but it prevents the emotional buy that undoes three months of discipline.

Exit velocity benchmarks

Track how many names you sold versus acquired each quarter. If acquisitions outpace exits for four straight quarters, your book is growing faster than your ability to monetize it. That ratio matters more than portfolio count bragging rights.

Cash reserve rule of thumb

Keep enough liquid capital to cover twelve months of renewals on the entire book without selling a single name. If you can't, you're over-levered on registrations relative to your balance sheet.

Key Takeaways:

  • Stress-test your portfolio before every major buy — assume slow sales and tight liquidity.
  • Map renewal bleed and capital lock-up; cut Tier C names fast.
  • Anchor asks to closed comps, not stale headlines or list prices.
  • Price dispute risk into holdings — UDRP isn't free or fast.
  • Keep dry powder; the best deals come from other people's failed stress tests.

Run the test, then shop with clarity — start at AudioNames.com or browse inventory, and read hold rate trends on the blog.

- DN Detector editorial